Meanwhile, the company today announced that Glenmark Pharmaceuticals. Inc, has been granted final approval by the US Food and Drug Administration (USFDA) for Clotrimazole and Betamethasone Dipropionate Cream USP, 1% | 0.05%, the therapeutic equivalent of Lotrisone Cream USP, 1% | 0.05% of Merck, Sharp and Dohme Corporation
| Subscribe To Our Free Newsletter |
